Cargando…
Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy
Target selection is a key feature in cancer immunotherapy, a promising field in cancer research. In this respect, gangliosides, a broad family of structurally related glycolipids, were suggested as potential targets for cancer immunotherapy based on their higher abundance in tumors when compared wit...
Autores principales: | Fleurence, Julien, Fougeray, Sophie, Bahri, Meriem, Cochonneau, Denis, Clémenceau, Béatrice, Paris, François, Heczey, Andras, Birklé, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244029/ https://www.ncbi.nlm.nih.gov/pubmed/28154831 http://dx.doi.org/10.1155/2017/5604891 |
Ejemplares similares
-
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
por: Fleurence, Julien, et al.
Publicado: (2016) -
A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity
por: Alvarez-Rueda, Nidia, et al.
Publicado: (2011) -
Biology of GD2 ganglioside: implications for cancer immunotherapy
por: Machy, Pierre, et al.
Publicado: (2023) -
Chimeric Antibody c.8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia
por: Terme, Mickaël, et al.
Publicado: (2014) -
CAR T Cell Therapy’s Potential for Pediatric Brain Tumors
por: Thomas, Pauline, et al.
Publicado: (2021)